Patients treated with radiotherapy showed superior swallowing-related QOL scores 1 year after treatment, although the difference did not represent a clinically meaningful change. Toxicity patterns differed between the groups. Patients with OPSCC should be informed about both treatment options.
Radiation is used to treat pancreatic ductal adenocarcinoma (PDAC) in the locally-advanced setting. Stereotactic body radiation therapy (SBRT), in particular, has shown improved outcomes against…
ASTRO holds annual elections for its Board of Directors.
Left coronary artery dose predictors may not fully model the risk of heart failure (HF) given the potential direct and indirect mechanisms of radiation-induced myocardial…
ASTRO’s weekly member newsletter for the week of July 7: 2025 Fellows Announced, ASTRO 2025 LBA deadline, ASTRO Elections, Advocacy Updates
Learn about the abstract submission process and guidelines for the 2025 ASTRO Annual Meeting.
The ASTRO-proposed Radiation Oncology Case Rate (ROCR) program represents a bold initiative to reverse disastrous payment trends that are expected to continue.
Press release to announce the 2025 class of ASTRO Fellows
A look into the daily life of Banu Atalar, MD, a radiation oncologist in Istanbul, Turkey, and president of the Turkish Society of Radiation Oncology.
ASTRO holds annual elections for its Board of Directors.
Learn about the abstract submission process and guidelines for the 2025 ASTRO Annual Meeting.
